CompoAtlas

CONCV PLUS FOR WOMEN

Food supplement declared in France

CONCV PLUS FOR WOMEN is a food supplement declared in France. Status: earlier declaration, replaced by the 2025 declaration. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
BIOROSAN
Status
Earlier declaration, replaced by the 2025 declaration : CONCV PLUS FOR WOMEN
Form
Sachet
Daily dose
1 Sachet
Directions for use
1 sachet par jour à diluer dans l'eau. Commencer à utiliser environ 90 jours avant la date souhaitée de grossesse et pour suivre l’utilisation tous les jours comme indiqué ou selon les conseils de votre professionnel de santé.
Intended populations
Femme
Not recommended for (according to the manufacturer)
Enfants (de moins de 10 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Cycles féminins, Autre : • Aide le corp à se préparer à la grossesse • Soutient avant, pendant et après la grossesse

Declaration 3858, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Other active ingredients

NamePer day
Taurinenot declared
Ubiquinonenot declared
Myo-inositolnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
D-biotineBiotine (vitamine B8)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Béta-carotèneBêta-carotènepas de limite (données insuffisantes)aucune dose fixée
Carbonate de calciumCalcium2,500 mg800 mg
Sulfate de cuivreCuivre5,000 µg2,000 µg
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
Iodate de potassiumIode600 µg150 µg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Sélénite de sodiumSélénium255 µg50 µg
Mononitrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Acétate de D-alpha-tocophéryleVitamine E300 mg30 mg

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • Ubiquinone
    Read the warning, when it applies and the studies cited

    Coenzyme Q10 (UBIQUINONE-10)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 100 mg of Coenzyme Q10 per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line